Microbot Medical Inc.
MBOT
$2.61
$0.187.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.67M | 4.70M | 4.39M | 4.26M | 4.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.63M | 10.26M | 9.51M | 9.32M | 9.86M |
| Operating Income | -11.63M | -10.26M | -9.51M | -9.32M | -9.86M |
| Income Before Tax | -11.44M | -11.21M | -10.44M | -10.26M | -10.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.44 | -11.21 | -10.44 | -10.26 | -10.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.44M | -11.21M | -10.44M | -10.26M | -10.74M |
| EBIT | -11.63M | -10.26M | -9.51M | -9.32M | -9.86M |
| EBITDA | -11.53M | -10.16M | -9.41M | -9.21M | -9.75M |
| EPS Basic | -0.73 | -0.80 | -0.81 | -0.89 | -1.08 |
| Normalized Basic EPS | -0.45 | -0.44 | -0.45 | -0.50 | -0.62 |
| EPS Diluted | -0.73 | -0.80 | -0.81 | -0.89 | -1.08 |
| Normalized Diluted EPS | -0.45 | -0.44 | -0.45 | -0.50 | -0.62 |
| Average Basic Shares Outstanding | 62.56M | 57.21M | 52.45M | 46.80M | 40.76M |
| Average Diluted Shares Outstanding | 62.56M | 57.21M | 52.45M | 46.80M | 40.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |